Evaluation of molecular monitoring and response milestone of patients with chronic myeloid leukemia to tyrosine kinase inhibitors in Middle Euphrates of Iraq

Background: In the last decade, tremendous changes occurred in the treatment and follow-up of the patients with chronic myeloid leukemia (CML), with continuous update in the close molecular monitoring of treatment for the presence of minimal residual disease. Objectives: The objective of this study...

Full description

Bibliographic Details
Main Authors: Rahem M Rahem, Alaa S Alaawad, Talib H Kamoona
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2016;volume=5;issue=2;spage=143;epage=148;aulast=Rahem